Abstract
Aim:
To construct a recombinant adenovirus that can simultaneously express both antisense ornithine decarboxylase (ODC) and adenosylmethionine decarboxylase (AdoMetDC) and detect its inhibitory effect on the intracellular polyamine pool and colorectal cancer cell growth.
Methods:
A205-bp cDNA of AdoMetDC was reverse-inserted into recombinant pAdTrack-ODCas vectors and recombined with pAdEasy-1 vectors in AdEasy-1 cells. Positive clones were selected and transfected into the packaging cell HEK293 after they were linearized by PacI. Green fluorescent protein expression was used to monitor the process of adenovirus packaging. The ODC and AdoMetDC protein levels were identified by western blotting, and intracellular polyamine content was detected by reverse-phase high performance liquid chromatography. A viable cell count was used to determine the growth of HT-29 cells with or without exogenous polyamine.
Results:
Sequencing confirmed that AdoMetDC cDNA was successfully ligated into the pAdTrack-ODCas vector. GFP expression in 293 cells during virus packing and amplification was observed by fluorescence microscopy. Western blotting demonstrated that both ODC and AdoMetDC were downregulated by Ad-ODC-AdoMetDCas, and consequently 3 kinds of polyamine (putrescine, spermidine and spermine) were reduced to very low levels. HT-29 cell growth was significantly inhibited as compared with control conditions, and growth arrest was not reversed by exogenous putrescine.
Conclusion:
The successfully constructed recombinant adenovirus, Ad-ODC-AdoMetDCas, blocked polyamine synthesis and has therapeutic potential for treating colorectal cancer in vitro.
Similar content being viewed by others
Article PDF
References
Morgan DM . Polyamines. An overview. Mol Biotechnol 1999; 11: 229–50.
Dandrifosse G, Deloyer P, Grandfils C, Loret S, Peulen O, Dandrifosse AC . Statement on polyamines. Rev Med Liege 1999; 54: 175–83.
Glikman P, Vegh I, Pollina MA, Mosto AH, Levy CM . Ornithine decarboxylase activity, prolactin blood levels, and estradiol and progesterone receptors in human breast cancer. Cancer 1987; 60: 2237–43.
Upp JR Jr, Saydjari R, Townsend CM Jr, Singh P, Barranco SC, Thompson JC . Polyamine levels and gastrin receptors in colon cancers. Ann Surg 1988; 207: 662–9.
Gerner EW, Meyskens FL Jr . Polyamines and cancer: old molecules, new understanding. Nat Rev Cancer. 2004; 4: 781–92.
Loser C, Folsch UR, Paprotny C, Creutzfeldt W . Polyamines in colorectal cancer. Evaluation of polyamine concentrations in the colon tissue, serum and urine of 50 patients with colorectal cancer. Cancer. 1990; 65: 958–66.
Higuchi CM, Wang W . Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J Cell Biochem 1995; 57: 256–61.
Sun AH, Liu XX, Zhang B . Expression and clinical implication of ODC mRNA in colorectal carcinoma. Chin J Curr Adv Gen Surg 2004; 7: 150–2.
Hu HY, Liu XX, Jiang CY, Lu Y, Zhang Y, Zhang B, et al. Ornithine decarboxylase gene is overexpressed in colorectal carcinoma. World J Gastroenterol 2005; 11: 2244–8.
Zhang Y, Liu XX, Zhang B, Hu HY, Gong L . Antitumor effect of antisense ODC adenovirus on human prostate cancer cells. Prostate Cancer Prostatic Dis 2005; 8: 280–6.
Zhang B, Liu XX, Jiang CY, Zhang Y, Hu HY, Geng Z . Construction of an antisense bicistronic recombinant adenovirus vector of ornithine decarboxylase and S-adenosylmethionine decarboxylase. J Shandong Univ (Health Sci) 2005; 43: 387–90.
Aboul-Enein HY, al-Duraibi IA . Separation of several free polyamines and their acetylated derivatives by ion-pair reversed-phase high performance liquid chromatography. Biomed Chromatogr 1998; 12: 291–3.
Wallace HM, Caslake R . Polyamines and colon cancer. Eur J Gastroenterol Hepatol 2001; 13: 1033–9.
Kinzler KW, Vogelstein B . Lessons from hereditary colorectal cancer. Cell 1996; 87: 159–70.
Wang JF, Su RB, Wu N, Xu B, Lu XQ, Liu Y . Inhibitory effect of agmatine on proliferation of tumor cells by modulation of polyamine metabolism. Acta Pharmacol Sin 2005; 26: 616–22.
Janne J, AIhonen L, Leinonen P . Polyamines: from molecular biology to clinical applications. Ann Med 1991; 23: 241–59.
Seiler N . Thirty years of polyamine-related approaches to cancer therapy. Retrospect and prospect. Part 2. Structural analogues and derivatives. Curr Drug Targets 2003; 4: 565–85.
Meyskens FL, Gerner EW . Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin Cancer Res 1999; 5: 945–51.
Loesberg C, Van Rooji H, Romijn JC, Smets LA . Mitochondrial effects of the guanidino group-containing cytostatic drugs, miodobenzylguanidine and methylglyoxal bis (guanylhydrazone). Biochem Pharmacol 1991; 42: 793–8.
Dorhout B, Odink MF, de Hoog EM, Kingma AW, van der Veer E, Muskiet FA . 4′-Aminoindan-1-one 2′-amidinohydrazone (CGP48664A) exerts in vitro growth inhibitory effects that are not only related to S-adenosylmethionine decarboxylase inhibition. Biochim Biophys Acta 1997; 1335: 144–52.
Yi C, Huang Y, Guo ZY, Wang SR . Antitumor effect of cytosine deaminase/5-fluorocytosine suicide gene therapy system mediated by Bifidobacterium infantis on melanoma. Acta Pharmacol Sin 2005; 26: 629–34.
Zhang SN, Yuan SZ, Zhu ZH, Wen ZF, Huang ZQ, Zeng ZY . Apoptosis induced by 5-flucytosine in human pancreatic cancer cells genetically modified to express cytosine deaminase. Acta Pharmacol Sin 2000; 21: 655–9.
Hu YC . Baculovirus as a highly efficient expression vector in insect and mammalian cells. Acta Pharmacol Sin 2005; 26: 405–16.
Li L, He DL . Transfection of promyelocytic leukemia in retrovirus vector inhibits growth of human bladder cancer cells. Acta Pharmacol Sin 2005; 26: 610–5.
Kanerva A, Hemminki A . Modified adenoviruses for cancer gene therapy. Int J Cancer 2004; 110: 475–80.
St George JA . Gene therapy progress and prospects: adenoviral vectors. Gene Ther 2003; 10: 1135–41.
Nowels K, Homma Y, Seidenfeld J, Oyasu R . Prevention of inhibitory effects of alpha-difluoromethylornithine on rat urinary bladder carcinogenesis by exogenous putrescine. Cancer Biochem Biophys 1986; 8: 257–63.
Thompson HJ, Ronan AM . Effect of D, L-2-difluoromethylorni-thine and endocrine manipulation on the induction of mammary carcinogenesis by 1-methyl-1-nitrosourea. Carcinogenesis 1986; 7: 2003–6.
Nigro ND, Bull AW, Boyd ME . Inhibition of intestinal carcinogenesis in rats: effect of difluoromethylornithine with piroxicam or fish oil. J Natl Cancer Inst 1986; 77: 1309–13.
Arbeit JM, Riley RR, Huey B, Porter C, Kelloff G, Lubet R, et al. Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14- HPV16 transgenic mice. Cancer Res 1999; 59: 3610–20.
Marton LJ, Pegg AE . Polyamines as targets for therapeutic intervention. Annu Rev Pharmacol Toxicol 1995; 35: 55–91.
Gamet L, Cazenave Y, Trocheris V, Denis-Pouxviel C, Murat JC . Involvement of ornithine decarboxylase in the control of proliferation of the HT29 human colon cancer cell line. Effect of vasoactive intestinal peptide on enzyme activity. Int J Cancer 1991; 47: 633–8.
McCormack SA, Johnson LR . Putrescine uptake and release by colon cancer cells. Am J Physiol 1989; 256: G868–77.
Desiderio MA, Bergamaschi D, Mascellani E, De Feudis P, Erba E, D'Incalci M . Treatment with inhibitors of polyamine biosynthesis, which selectively lower intracellular spermine, does not affect the activity of alkylating agents but antagonizes the cytotoxicity of DNA topoisomerase II inhibitors. Br J Cancer 1997; 75: 1028–34.
Author information
Authors and Affiliations
Corresponding author
Additional information
Project supported by the Foundation of Department of Science and Technology of Shandong Province, and the Doctoral Foundation of Ministry of Education (No 2004042029).
Rights and permissions
About this article
Cite this article
Zhang, B., Liu, Xx., Zhang, Y. et al. Adenovirus-mediated expression of both antisense ODC and AdoMetDC inhibited colorectal cancer cell growth in vitro. Acta Pharmacol Sin 27, 353–359 (2006). https://doi.org/10.1111/j.1745-7254.2006.00268.x
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1111/j.1745-7254.2006.00268.x
Keywords
This article is cited by
-
Targeting polyamine biosynthetic pathway through RNAi causes the abrogation of MCF 7 breast cancer cell line
Tumor Biology (2016)
-
Recent developments in the use of adenoviruses and immunotoxins in cancer gene therapy
Cancer Gene Therapy (2007)